ouabain has been researched along with humulene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chau-Wong, M; Moyyen, S; Seeman, P | 1 |
| Loetzer, R; Schaefer, JF; Sofia, RD | 1 |
| Bär, PR; Nicolay, K; van der Stelt, M; Veldhuis, WB; Veldink, GA; Vliegenthart, JF | 1 |
3 other study(ies) available for ouabain and humulene
| Article | Year |
|---|---|
The membrane binding of morphine, diphenylhydantoin, and tetrahydrocannabinol.
Topics: Adenosine Triphosphate; Animals; Brain; Cannabis; Carbon Isotopes; Cell Membrane; Dinitrophenols; Dronabinol; Erythrocytes; Guinea Pigs; Humans; In Vitro Techniques; Membranes; Morphine; Nerve Endings; Neural Conduction; Ouabain; Phenytoin; Saponins; Synaptic Vesicles; Synaptosomes; Temperature; Time Factors | 1972 |
Effect of delta 1-tetrahydrocannabinol and propranolol on ouabain induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cannabis; Dogs; Dronabinol; Electrocardiography; Ethanol; Heart Rate; Male; Ouabain; Propranolol; Time Factors | 1973 |
Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity.
Topics: Acute Disease; Animals; Animals, Newborn; Brain; Brain Edema; Cannabis; Chronic Disease; Corpus Striatum; Dose-Response Relationship, Drug; Dronabinol; Enzyme Inhibitors; Longitudinal Studies; Magnetic Resonance Imaging; Microinjections; Neuroprotective Agents; Ouabain; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Sodium-Potassium-Exchanging ATPase; Water | 2001 |